Geode Capital Management, LLC Edesa Biotech, Inc. Transaction History

Geode Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.63 - $0.99 $10,139 - $15,933	16,094 Added 18.56%	102,790 $64,000
Q4 2022 Feb 13, 2023	BUY	$0.8 - $8.05 $3,398 - $34,196	4,248 Added 5.15%	86,696 $187,000
Q2 2022 Aug 12, 2022	BUY	$1.47 - $2.94 $3,203 - $6,406	2,179 Added 2.71%	82,448 $131,000
Q1 2022 May 13, 2022	BUY	$2.72 - $5.97 $8,214 - $18,029	3,020 Added 3.91%	80,269 $238,000
Q3 2021 Nov 12, 2021	BUY	$4.2 - $11.92 $13,511 - $38,346	3,217 Added 4.35%	77,249 $570,000
Q2 2021 Aug 13, 2021	BUY	$4.93 - $6.69 $220,878 - $299,732	44,803 Added 153.28%	74,032 $390,000
Q1 2021 May 12, 2021	BUY	$4.3 - $7.48 $125,684 - $218,632	29,229 New	29,229 $157,000

Ticker EDSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,462,300
Market Cap $32.3M
Description
Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress s...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.